Supernus Pharmaceuticals, Inc. (SUPN)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.58B |
| Enterprise value | 1.37B |
| Trailing P/E | 1.44k |
| Forward P/E | 20.16 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.64 |
| Price/book (mrq) | 1.72 |
| Enterprise value/revenue | 2.25 |
| Enterprise value/EBITDA | 15.19 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.99 |
| 52-week change 3 | -25.46% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 39.09 |
| 52-week low 3 | 21.99 |
| 50-day moving average 3 | 31.15 |
| 200-day moving average 3 | 29.08 |
Share statistics
| Avg vol (3-month) 3 | 397.7k |
| Avg vol (10-day) 3 | 395.51k |
| Shares outstanding 5 | 54.73M |
| Implied shares outstanding 6 | 55.78M |
| Float 8 | 47.71M |
| % held by insiders 1 | 5.12% |
| % held by institutions 1 | 108.16% |
| Shares short (28 Mar 2024) 4 | 4.82M |
| Short ratio (28 Mar 2024) 4 | 9.64 |
| Short % of float (28 Mar 2024) 4 | 13.27% |
| Short % of shares outstanding (28 Mar 2024) 4 | 8.81% |
| Shares short (prior month 29 Feb 2024) 4 | 4.41M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.22% |
| Operating margin (ttm) | 11.56% |
Management effectiveness
| Return on assets (ttm) | 0.56% |
| Return on equity (ttm) | 0.15% |
Income statement
| Revenue (ttm) | 607.52M |
| Revenue per share (ttm) | 11.14 |
| Quarterly revenue growth (yoy) | -1.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 98.26M |
| Net income avi to common (ttm) | 1.32M |
| Diluted EPS (ttm) | 0.02 |
| Quarterly earnings growth (yoy) | -95.40% |
Balance sheet
| Total cash (mrq) | 254.87M |
| Total cash per share (mrq) | 4.66 |
| Total debt (mrq) | 41.53M |
| Total debt/equity (mrq) | 4.51% |
| Current ratio (mrq) | 1.70 |
| Book value per share (mrq) | 16.84 |
Cash flow statement
| Operating cash flow (ttm) | 111.08M |
| Levered free cash flow (ttm) | 161.71M |
© 2024 Yahoo. All rights reserved.